1) Jemal A, Siegel R, Ward E, et al : Cancer statistics, 2007. CA Cancer J Clin 57 : 43─66, 2007
2) Gershenson DM : Management of ovarian germ cell tumors. J Clin Oncol 25 : 2938─2943, 2007
3) 婦人科腫瘍委員会報告.日産婦誌59 : 901─982, 2007
4) Colombo N, Chiari S, Maggioni A, et al : Controversial issues in the management of early epithelial ovarian cancer : conservative surgery and role of adjuvant therapy. Gynecol Oncol 55 : S47─51, 1994
5) Zanetta G, Chiari S, Rota S, et al : Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 104 : 1030─1035, 1997
6) Morice P, Wicart─Poque F, Rey A, et al : Results of conservative treatment in epithelial ovarian carcinoma. Cancer 92 : 2412─2418, 2001
7) Schilder JM, Thompson AM, DePriest PD, et al : Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility─sparing therapy. Gynecol Oncol 87 : 1─7, 2002
8) Morice P, Leblanc E, Rey A, et al : Conservative treatment in epithelial ovarian cancer : results of a multicentre study of the GCCLCC(Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)and SFOG(Societe Francaise d’Oncologie Gynecologique).Hum Reprod 20 : 1379─1385, 2005
9) Colombo N, Parma G, Lapresa MT, et al : Role of conservative surgery in ovarian cancer : the European experience. Int J Gynecol Cancer 15 : 206─211, 2005
10) Raspagliesi F, Fontanelli R, Paladini D, et al : Conservative surgery in high─risk epithelial ovarian carcinoma. J Am Coll Surg 185 : 457─460, 1997
11) Fader AN, Rose PG : Role of surgery in ovarian carcinoma. J Clin Oncol 20 : 2873─2883, 2007
12) 日本婦人科腫瘍学会(編) : 卵巣がん治療ガイドライン2007年版.金原出版,2007
13) Baiocchi G, Raspagliesi F, Grosso G, et al : Early ovarian cancer : Is there a role for systemiatic pelvic and para─aortic lymphadenectomy? Int J Gynecol Cancer 8 : 103─108, 1998
14) Panici PB, Maggioni A, Hacker N, et al : Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer : a randomized clinical trial. J Natl Cancer Inst 97 : 560─566, 2005
15) Panici PB, Greggi S, Maneschi F, et al : Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Onclol 51 : 150─154, 1993
16) Onda T, Yoshikawa H, Yokota H, et al : Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy. Cancer 78 : 803─808, 1996
17) Walter AJ, Magrina JF : Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer. Gynecol Oncol 74 : 128─129, 1999
18) Suzuki M, Ohwada M, Yamada T, et al : Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol 79 : 305─308, 2000
19) Petru E, Lahousen M, Tamussino K, et al : Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170 : 656─662, 1994
20) Munnell EW : Is conservative therapy ever justified in stageI(IA)cancer of the ovary? Am J Obstet Gynecol 103 : 641─653, 1969
21) DiSaia PJ : Conservative management of the patient with early gynecologic cancer. CA Cancer J Clin 39 : 135─154, 1989
22) Benjamin I, Morgan MA, Rubin SC : Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 72 : 288─291, 1999
23) Plante M : Fertility preservation in the management of gynecologic cancers. Curr Opin Oncol 12 : 497─507, 2000
24) McHale MT, DiSaia PJ : Fertility─sparing treatment of patients with ovarian cancer. Comp Ther 25 : 144─150, 1999
25) Sugiyama T, Kamura T, Kigawa J, et al : Clinical characteristics of clear cell carcinoma of the ovary : a distinct histologic type with poor prognosis and resistance to platinum─based chemotherapy. Cancer 88 : 2584─2589, 2000